INTERNATIONAL
Russia is most trusted vaccine producer - YouGov survey
Respondents in a survey trust Russia the most in regards to COVID-19 vaccine production.
Respondents in a survey trust Russia the most in regards to COVID-19 vaccine production.
This is according to report released by British market research company YouGov that discovered that 54% of 9,417 respondents from 9 countries said they trusted Russia, followed by the United States in second with 53.9% trust rate. The United Kingdom came in third with 48.4%.
The Russian Direct Investment Fund (RDIF), which backed the production of COVID-19 vaccine Sputnik V, released the report on Wednesday.
Meanwhile, when participants were asked which vaccine they would be willing to get themselves, most people named the Pfizer-BioNTech vaccine as first choice at 37 percent, Sputnik V came in second at 33 percent and SinoVac at third.
"Thanks to the outstanding achievements of Russian science, the Sputnik V vaccine has been saving lives around the world as it is approved for use in more than 50 countries. The vaccine has a number of key benefits, including an efficacy of 91.6%, confirmed by the leading medical journal The Lancet, as well as a proven to be safe human adenoviral vector platform, attractive supply chain logistics and affordability, making Sputnik V one of the best vaccines in the world," says Kirill Dmitriev, the CEO of RDIF.
This is according to report released by British market research company YouGov that discovered that 54% of 9,417 respondents from 9 countries said they trusted Russia, followed by the United States in second with 53.9% trust rate. The United Kingdom came in third with 48.4%.
The Russian Direct Investment Fund (RDIF), which backed the production of COVID-19 vaccine Sputnik V, released the report on Wednesday.
Meanwhile, when participants were asked which vaccine they would be willing to get themselves, most people named the Pfizer-BioNTech vaccine as first choice at 37 percent, Sputnik V came in second at 33 percent and SinoVac at third.
"Thanks to the outstanding achievements of Russian science, the Sputnik V vaccine has been saving lives around the world as it is approved for use in more than 50 countries. The vaccine has a number of key benefits, including an efficacy of 91.6%, confirmed by the leading medical journal The Lancet, as well as a proven to be safe human adenoviral vector platform, attractive supply chain logistics and affordability, making Sputnik V one of the best vaccines in the world," says Kirill Dmitriev, the CEO of RDIF.
#COVID-19
#Pfizer-BioNTech
#Russia
#United Kingdom
#United States
#Sputnik V
#Sinovac
#RDIF
#Kirill Dmitriev